1.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443

2.
Interpretation of the evidence for the efficacy and safety of statin therapy
by Collins, Rory, Prof
The Lancet (British edition), 2016, Vol.388 (10059), p.2532-2561

3.
Polypills for the prevention of cardiovascular disease: a framework for wider use
by Patel, Anushka
Nature medicine, 2022-02, Vol.28 (2), p.226-229

4.
Blood-pressure-related disease is a global health priority
by MacMahon, Stephen
American journal of hypertension, 2008, Vol.371 (9623), p.1480-1482

5.
Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): A factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention s...
by Chow, Clara K., MBBS, FRACP, PhD
The American heart journal, 2009, Vol.158 (3), p.349-355

6.
Differences between blood-pressure-lowering drugs
by MacMahon, Stephen
The Lancet (British edition), 2000, Vol.356 (9227), p.352-353

7.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
by Sundström, Johan
The Lancet (British edition), 2014-08-16, Vol.384 (9943), p.591-598

8.
An Economic Evaluation of a Perindopril-Based Blood Pressure Lowering Regimen for Patients Who Have Suffered a Cerebrovascular Event
by Tavakoli, Manouchehr
The European journal of health economics, 2009-02-01, Vol.10 (1), p.111-119

9.
Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor–Based Regimens: An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials
by Bell, Katy J.L
Hypertension (Dallas, Tex. 1979), 2010-09, Vol.56 (3), p.533-539

10.
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease
by Katsuya, T
The Lancet (British edition), 1995-06-24, Vol.345 (8965), p.1600-1603
